Work

Pre-Exposure Prophylaxis for HIV in Primary Care and Beyond.

Year: 2022

Type: article

Abstract: HIV pre-exposure prophylaxis (PrEP) is antiretroviral medication used to prevent HIV in patients at increased risk of acquisition due to sexual practices or intravenous drug use. Despite strong evidence of efficacy and safety, PrEP is currently underutilized in the United States. Initial testing includes HIV, hepatitis B, and renal function. There are currently two oral medications approved for daily use within the U.S.; regular monitoring for HIV and renal dysfunction is required with both medications.

Source: PubMed

Authors: Theresa Drallmeier, Ashley Meyr

Institution: Saint Louis University

Language: English

Topic: HIV/AIDS Research and Interventions

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W4293516471

FWCI: 0.252

Cites: 27

Cited by: 3

Related to: 10